Healthpeak Properties Inc
SWB:HC5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healthpeak Properties Inc
SWB:HC5
|
US |
|
B
|
Bank of Nova Scotia
BMV:BNS
|
CA |
|
W
|
Weyerhaeuser Co
DUS:WHC
|
US |
|
T
|
Teradyne Inc
LSE:0LEF
|
US |
Wall St Price Targets
HC5 Price Targets Summary
Healthpeak Properties Inc
According to Wall Street analysts, the average 1-year price target for HC5 is 16.741 EUR with a low forecast of 13.712 EUR and a high forecast of 25.836 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HC5's stock price target?
Price Target
16.741
EUR
According to Wall Street analysts, the average 1-year price target for HC5 is 16.741 EUR with a low forecast of 13.712 EUR and a high forecast of 25.836 EUR.
What is the Revenue forecast for Healthpeak Properties Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Healthpeak Properties Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been -6%. The projected CAGR for the next 8 years is 5%.
What is the Net Income forecast for Healthpeak Properties Inc?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Net Income has been -17%. The projected CAGR for the next 8 years is 23%.
